These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 36721954)

  • 1. Endovascular revascularization strategies for aortoiliac and femoropopliteal artery disease: a meta-analysis.
    Koeckerling D; Raguindin PF; Kastrati L; Bernhard S; Barker J; Quiroga Centeno AC; Raeisi-Dehkordi H; Khatami F; Niehot C; Lejay A; Szeberin Z; Behrendt CA; Nordanstig J; Muka T; Baumgartner I
    Eur Heart J; 2023 Mar; 44(11):935-950. PubMed ID: 36721954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative effectiveness of endovascular treatment modalities for de novo femoropopliteal lesions at long-term follow-up: A network meta-analysis of randomized controlled trials.
    Zhou Y; Wang T; He H; Li Q; Wan Z; Lu P; Shu C
    Int J Cardiol; 2024 Jun; 404():131977. PubMed ID: 38508322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative effectiveness of endovascular treatment modalities for de novo femoropopliteal lesions in intermittent claudication: A network meta-analysis of randomized controlled trials.
    Zhou Y; Wang J; He H; Li Q; Li M; Li X; Shu C
    Int J Cardiol; 2021 Nov; 343():122-130. PubMed ID: 34461162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Robustness of Longitudinal Safety and Efficacy After Paclitaxel-Based Endovascular Therapy for Treatment of Femoro-Popliteal Artery Occlusive Disease: An Updated Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    D'Oria M; Mastrorilli D; Secemsky E; Behrendt CA; Veraldi G; DeMartino R; Mani K; Budtz-Lilly J; Scali S; Saab F; Calvagna C; Mezzetto L; Ruaro B; Lepidi S
    Ann Vasc Surg; 2024 Apr; 101():164-178. PubMed ID: 38154491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug-eluting balloon angioplasty versus uncoated balloon angioplasty for peripheral arterial disease of the lower limbs.
    Kayssi A; Al-Atassi T; Oreopoulos G; Roche-Nagle G; Tan KT; Rajan DK
    Cochrane Database Syst Rev; 2016 Aug; 2016(8):CD011319. PubMed ID: 27490003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Meta-Analysis Comparing Endovascular Treatment Modalities for Femoropopliteal Peripheral Artery Disease.
    Khan MS; Zou F; Khan AR; Moustafa A; Schmid CH; Baig M; Hyder ON; Aronow HD
    Am J Cardiol; 2020 Aug; 128():181-188. PubMed ID: 32650917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug-eluting balloon angioplasty versus uncoated balloon angioplasty for the treatment of in-stent restenosis of the femoropopliteal arteries.
    Kayssi A; Al-Jundi W; Papia G; Kucey DS; Forbes T; Rajan DK; Neville R; Dueck AD
    Cochrane Database Syst Rev; 2019 Jan; 1(1):CD012510. PubMed ID: 30684445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angioplasty or bare metal stent versus drug-eluting endovascular treatment in femoropopliteal artery disease: a systematic review and meta-analysis.
    Varetto G; Gibello L; Boero M; Frola E; Peretti T; Spalla F; Verzini F; Rispoli P
    J Cardiovasc Surg (Torino); 2019 Oct; 60(5):546-556. PubMed ID: 31527577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heparin-bonded covered stents versus bare-metal stents for complex femoropopliteal artery lesions: the randomized VIASTAR trial (Viabahn endoprosthesis with PROPATEN bioactive surface [VIA] versus bare nitinol stent in the treatment of long lesions in superficial femoral artery occlusive disease).
    Lammer J; Zeller T; Hausegger KA; Schaefer PJ; Gschwendtner M; Mueller-Huelsbeck S; Rand T; Funovics M; Wolf F; Rastan A; Gschwandtner M; Puchner S; Ristl R; Schoder M
    J Am Coll Cardiol; 2013 Oct; 62(15):1320-7. PubMed ID: 23831445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug Eluting Stent vs. Drug Coated Balloon for Native Femoropopliteal Artery Disease: A Two Centre Experience.
    Lee YJ; Kook H; Ko YG; Yu CW; Joo HJ; Ahn CM; Choi D
    Eur J Vasc Endovasc Surg; 2021 Feb; 61(2):287-295. PubMed ID: 33223281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Laser atherectomy and drug-coated balloons for the treatment of femoropopliteal in-stent restenosis: 2-Year outcomes.
    Kokkinidis DG; Behan S; Jawaid O; Hossain P; Giannopoulos S; Singh GD; Laird JR; Valle JA; Waldo SW; Armstrong EJ
    Catheter Cardiovasc Interv; 2020 Feb; 95(3):439-446. PubMed ID: 31816169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systematic review and updated meta-analysis of the use of drug-coated balloon angioplasty versus plain old balloon angioplasty for femoropopliteal arterial disease.
    Caradu C; Lakhlifi E; Colacchio EC; Midy D; Bérard X; Poirier M; Ducasse E
    J Vasc Surg; 2019 Sep; 70(3):981-995.e10. PubMed ID: 31126769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative Effectiveness of Plain Balloon Angioplasty, Bare Metal Stents, Drug-Coated Balloons, and Drug-Eluting Stents for the Treatment of Infrapopliteal Artery Disease: Systematic Review and Bayesian Network Meta-analysis of Randomized Controlled Trials.
    Katsanos K; Kitrou P; Spiliopoulos S; Diamantopoulos A; Karnabatidis D
    J Endovasc Ther; 2016 Dec; 23(6):851-863. PubMed ID: 27708143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative Effectiveness of Endovascular Treatment Modalities for De Novo Femoropopliteal Lesions: A Network Meta-analysis of Randomized Controlled Trials.
    Zhou Y; Zhang Z; Lin S; Xiao J; Ai W; Wang J; Li Y; Li Q
    J Endovasc Ther; 2020 Feb; 27(1):42-59. PubMed ID: 31948375
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparison of Drug-Coated Balloons vs Bare-Metal Stents in Patients With Femoropopliteal Arterial Disease.
    Shishehbor MH; Scheinert D; Jain A; Brodmann M; Tepe G; Ando K; Krishnan P; Iida O; Laird JR; Schneider PA; Rocha-Singh KJ; Zeller T
    J Am Coll Cardiol; 2023 Jan; 81(3):237-249. PubMed ID: 36332764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes of Drug-Coated Balloon Angioplasty vs. Conventional Balloon Angioplasty for Endovascular Treatment of Common Femoral Artery Atherosclerotic Disease.
    Cantu D; Jawaid O; Kokkinidis D; Giannopoulos S; Valle JA; Waldo SW; Singh GD; Armstrong EJ
    Cardiovasc Revasc Med; 2020 Jul; 21(7):867-874. PubMed ID: 31761636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nationwide trends in drug-coated balloon and drug-eluting stent utilization in the femoropopliteal arteries.
    Mohapatra A; Saadeddin Z; Bertges DJ; Madigan MC; Al-Khoury GE; Makaroun MS; Eslami MH
    J Vasc Surg; 2020 Feb; 71(2):560-566. PubMed ID: 31405761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug-coated balloons to improve femoropopliteal artery patency: Rationale and design of the LEVANT 2 trial.
    Jaff MR; Rosenfield K; Scheinert D; Rocha-Singh K; Benenati J; Nehler M; White CJ
    Am Heart J; 2015 Apr; 169(4):479-85. PubMed ID: 25819854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and Efficacy of Drug-Coated Balloon Angioplasty for the Treatment of Chronic Limb-Threatening Ischemia: A Systematic Review and Meta-Analysis.
    Giannopoulos S; Ghanian S; Parikh SA; Secemsky EA; Schneider PA; Armstrong EJ
    J Endovasc Ther; 2020 Aug; 27(4):647-657. PubMed ID: 32508220
    [No Abstract]   [Full Text] [Related]  

  • 20. A Single-Center Study on the Outcomes of Target Limb Revascularization in Femoropopliteal Lesions Treated With Drug Coated Balloons and Bare Metal Stents.
    Linehan V; Doyle M; Barrett B; Gullipalli R
    J Endovasc Ther; 2022 Dec; 29(6):948-955. PubMed ID: 34986705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.